Session Details
[27-16-pm]Gene DDS
Thu. Mar 27, 2025 3:10 PM - 4:46 PM JST
Thu. Mar 27, 2025 6:10 AM - 7:46 AM UTC
Thu. Mar 27, 2025 6:10 AM - 7:46 AM UTC
Room 16 (MARINE MESSE FUKUOKA Hall B: Conference Room1-2 [2F])
Chair: Tetsuya Nakamura, Mohri Kohta
[27-16-pm09S]Release of Damage-associated molecular patterns from Tumor cells by Reovirus, a tumor-associated virus.
○Yuto Maeda1, Maho Eguchi2, Ikuho Ishigami2, Naomi Shuwari2, Masashi Tachibana2, Hiroaki Shimada1, Atushi Kawase1, Ken Ishii3, Hiroyuki Mizuguchi2,4,5,6,7, Fuminori Sakurai1,2 (1. Fac. Pharm., Kindai Univ, 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. The Inst. Med Sci. Univ. Tokyo, 4. Natl. Inst. Biomed. Innov. Health Nutr., 5. MEIC, Osaka Univ., 6. OTRI, Osaka Univ., 7. CiDER, Osaka Univ.)
[27-16-pm10S]Development of a system for evaluating spatial distribution of nanoparticles in cancer tissue using H2O2 treatment and Seebest-PP: Application to malignant melanoma melanoma
○Kaisei Ono1, Makoto Matumoto1, Akari Kiguchi2, Shogo Nishida3, Shohei Takasugi3, Takeshi Terada3, Yusuke Eto3, Hikaru Sugihara3, Shintaro Fumoto1,2, Hidefumi Mukai1,2, Shigeru Kawakami1,2 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. Sch. Pharm. Sci., Nagasaki Univ., 3. Ono Pharmaceutical Co., LTD.)
[27-16-pm11S]Efficient knock-down of target genes by using a CRISPR-Cas13 system-expressing adenovirus vector in vitro and in vivo.
○Yuki Osakada1, Sota Kidawara2, Eiko Sakai1, Akira Asayama1, Kahori Shimizu1,2, Fuminori Sakurai3, Hiroyuki Mizuguchi1,2,4,5,6,7 (1. Graduate School of Pharmaceutical Sciences, Osaka University., 2. School of Pharmaceutical Sciences, Osaka University., 3. Department of Pharmacy, Kindai Universiry., 4. National Institute of Biomedical Innovation, Health and Nutrition., 5. Global Center for Medical Engineering and Informatics, Osaka University., 6. Institute for Open and Transdisciplinary Research Initiatives, Osaka University., 7. Center for Infectious Disease Education and Research, Osaka University.)
[27-16-pm12S]Development of inhalation powder containing adeno-associated viral vector based on spray-freeze-drying technology
○Motoki Sugiura1, Tomoyuki Okuda1, Hirokazu Okamoto1 (1. Grad. Sch. Pharm. Sci., Meijo Univ.)
[27-16-pm13S]Evaluation of genome edition using CRISPR-Cas12a adenovirus vectors reveals their efficient suppression of hepatitis B virus antigen production
○Eriko Yoshimitsu1, Eiko Sakai2, Tomohito Tsukamoto2, Chiharu Imamura1, Yukiko Ueyama(Toba)1,2,3,4, Koichi Watashi5, Fuminori Sakurai1,2, Kazuaki Chayama6, Hiroyuki Mizuguchi1,2,3,4,7,8 (1. Sch. of Pharm. Sci., Osaka Univ., 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI, Osaka Univ., 5. NIID, 6. HISINLSC, 7. MEI center, Osaka Univ., 8. CiDER, Osaka Univ.)
[27-16-pm14S]Preparation of gene/nucleic acid loaded nanobubbles using cationic oligomer for systemic delivery
○Taiki Yamaguchi1, Yoko Endo-Takahashi1,2, Yuni Onishi2, Shohei Suzuki2, Yoichi Negishi1,2 (1. Grad. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)
[27-16-pm15]Cyclic disulfide-modified lipid nanoparticles for efficient mRNA delivery and their application to cancer vaccines
○Seigo Kimura1, Kana Okada2, Susumu Tsutsumi2, Naoko Abe2, Hiroshi Abe2,3 (1. Integrated Research Consortium on Chemical Sciences, Nagoya University, 2. Grad. Sch. Sci., Nagoya University, 3. Institute for Glyco-core Research)
[27-16-pm16S]The development of simian adenovirus 25-based vector and evaluation of transduction properties
○Fuka Okumura1, Sora Tokuoka1, Naoya Nagata2, Rika Onishi2, Aoi Shiota2, Fuminori Sakurai2,3, Kahori Shimizu1,2, Hiroyuki Mizuguchi1,2,4,5,6,7 (1. Sch. of Pharm. Sci., Osaka Univ., 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. Sch. of Pharm. Sci., Kindai Univ., 4. MEI center, Osaka Univ., 5. OTRI, Osaka Univ., 6. CiDER, Osaka Univ., 7. NIBIOHN)